Bavarian Nordic A/S
Bavarian Nordic A/S (BVNKF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Bavarian Nordic A/S (BVNKF), featuring income statements, balance sheets, and cash flow data.
Bavarian Nordic A/S (BVNKF) Income Statement & Financial Overview
Explore comprehensive income reports for Bavarian Nordic A/S BVNKF, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.35B | $2.09B | $1.36B | $1.43B |
Cost of Revenue | $665.95M | $839.90M | $783.76M | $707.55M |
Gross Profit | $680.64M | $1.25B | $579.60M | $719.95M |
Gross Profit Ratio | $0.51 | $0.60 | $0.43 | $0.50 |
R&D Expenses | $172.11M | $203.54M | $264.28M | $209.59M |
SG&A Expenses | $249.65M | $341.24M | $221.75M | $244.47M |
Operating Expenses | $421.76M | $544.77M | $486.03M | $454.06M |
Total Costs & Expenses | $1.09B | $1.38B | $1.27B | $1.16B |
Interest Income | $7.69M | $12.59M | $9.36M | $9.55M |
Interest Expense | $2.80M | $4.34M | $3.65M | $2.44M |
Depreciation & Amortization | $160.66M | $163.63M | $156.89M | $153.65M |
EBITDA | $396.27M | $921.91M | $252.84M | $441.03M |
EBITDA Ratio | $0.29 | $0.44 | $0.19 | $0.31 |
Operating Income | $258.89M | $709.20M | $93.57M | $265.89M |
Operating Income Ratio | $0.19 | $0.34 | $0.07 | $0.19 |
Other Income/Expenses (Net) | -$29.34M | $37.85M | -$21.11M | $97000.00 |
Income Before Tax | $229.55M | $747.05M | $72.46M | $265.99M |
Income Before Tax Ratio | $0.17 | $0.36 | $0.05 | $0.19 |
Income Tax Expense | $10.79M | -$23.76M | $1.97M | $4.86M |
Net Income | $218.76M | $770.81M | $70.49M | $261.13M |
Net Income Ratio | $0.16 | $0.37 | $0.05 | $0.18 |
EPS | $2.70 | $9.84 | $0.90 | $3.30 |
Diluted EPS | $2.70 | $9.84 | $0.90 | $3.30 |
Weighted Avg Shares Outstanding | $81.02M | $78.57M | $78.32M | $79.13M |
Weighted Avg Shares Outstanding (Diluted) | $81.02M | $78.57M | $78.32M | $79.13M |
Over the past four quarters, Bavarian Nordic A/S demonstrated steady revenue growth, increasing from $1.43B in Q2 2024 to $1.35B in Q1 2025. Operating income reached $258.89M in Q1 2025, maintaining a consistent 19% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $396.27M, reflecting operational efficiency. Net income dropped to $218.76M, with EPS at $2.70. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan